Developer docs
API playgroundTry for free, no card

Search company profiles

Molecular Attraction

Full company profile

uuid0004bn9

Namestring
Molecular Attraction
Legal namestring
Molecular Attraction AB
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Molecular Attraction AB is a Swedish bio-attractant discovery company that develops species-specific pheromone-based products to control mosquitoes that transmit dengue, malaria, Zika, and chikungunya. Its platform isolates male aggregation pheromones directly from mosquito swarms and combines them with patented HMBPP phagostimulant compositions to disrupt mating, swarming, and feeding behavior in Anopheles, Aedes, and Culex species without affecting pollinators or other insects. Core products include pheromone blends, phagostimulants, and attractants delivered through NFC-tagged passive dispensers that release for 12 months at 1–2 grams per hectare per day, with no electricity or maintenance required. Field-validated performance includes an 80% mosquito population reduction reported in a 2024 whole-season trial in Dalarna, Sweden.

The company monetizes through hardware sales of pheromone dispensers priced at $0.26 per person protected at full deployment and $0.96 per person during pilots, with pilot deployments structured as multi-year contracts. Go-to-market is a hybrid model: an Early Access Partnership Program for commercial properties (hospitality, leisure, municipal buyers) and humanitarian deployments channeled through UNHCR, beginning with a 2025 pilot covering 143,000 Rohingya refugees in Cox's Bazar at a $137,000 contract value, with a 33-camp rollout to over 1 million people planned for 2027. Customers and trial sites span Sweden, the Seychelles, Spain, Argentina, and Bangladesh. The company is founder-led by Prof. Noushin Emami (Chief Scientific Officer) and chaired by Johan Paleovrachas, with Lech Ignatowicz as CEO, and is backed by Almi Invest, Farvatn Venture, the EIC Accelerator, EQT Foundation, Norrsken, Vinnova, and the European Union, alongside research collaborations with Karolinska Institute and the Liverpool School of Tropical Medicine.

Short descriptiontext

Molecular Attraction is a Swedish bio-attractant company that develops patented, species-specific pheromone and phagostimulant dispensers for low-cost, maintenance-free mosquito control, serving humanitarian organizations, governments, and hospitality buyers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNacka, Sweden
HQ citystring
Nacka
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mosquito control solutions, pheromone-based pest control, vector control products, bio-attractant discovery, species-specific attractants
Industry1 code
PRIMARYAFABAEAG
Semiochemicals & Pheromone-Based Control (Mating Disruption, Attract-and-Kill)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
NAICS code4 codes
  • Pesticide and Other Agricultural Chemical Manufacturing32532
  • Exterminating and Pest Control Services56171
  • Surface Active Agent Manufacturing325613
  • Pesticide and Other Agricultural Chemical Manufacturing325320
SIC code3 codes
  • Agricultural Chemicals2870
  • Industrial Organic Chemicals2860
  • Miscellaneous Chemical Products2890
Product category
Pheromone-based mosquito control products
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Pheromone Dispensers
TypeHardware Sales
Description

Sale of patented pheromone dispensers for mosquito control. Products are designed for continuous passive release over 12 months, installed once and running maintenance-free. Pricing at $0.26 per person at full deployment and $0.96 per person during pilot phase.

molecular-attraction.com
2Pilot Program Revenue
TypeOne Time License
Description

Revenue from pilot deployments with organizations like UNHCR. The Rohingya refugee camp pilot costs $137,000 total, protecting 143,000 people at $0.96 per person. Full rollout projected at $290,000 for over 1 million people.

molecular-attraction.com
3Early Access Partnership Program
TypeOne Time License
Description

Exclusive pre-market access program for properties to receive targeted pheromone control technology before competitors. Limited onboarding for high-touch integration.

molecular-attraction.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Pricing details2 tiers
1Full deployment pricing: $0.26 per person protected per year
ModelUnit PricingBilling cadenceAnnual
Notes

At full deployment, pheromone dispensers cost $0.26 per person protected annually, making it cheaper than all major alternatives in global health: bednets ($1.50), rural IRS ($3.48), larviciding ($4.50), fogging ($5.50), IRS pirimiphos-methyl ($7.06).

molecular-attraction.com
2Pilot deployment pricing: $0.96 per person protected per year
ModelUnit PricingBilling cadenceMulti-year contract
Notes

UNHCR Rohingya refugee camp pilot: $137,000 total cost to protect 143,000 people at $0.96 per person. Full rollout to 33 camps planned for 2027 at ~$290,000 to protect over 1 million people.

molecular-attraction.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Molecular Attraction develops and sells species-specific pheromone-based mosquito control products, including patented synthetic pheromone blends, HMBPP phagostimulant compositions, and species-specific attractants. The active ingredients are delivered via NFC-tagged pheromone dispensers that release continuously for 12 months at 1–2 grams per hectare per day, designed for installation by non-specialists without electricity or maintenance. The company's products are used by humanitarian organizations, government public health authorities, and leisure/hospitality properties to control Anopheles, Aedes, and Culex mosquitoes.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 80% mosquito population reduction in field trials (2024, Dalarna Region Sweden)
+5 more records
Product overview1 text field

Molecular Attraction develops a portfolio of pheromone-based mosquito control products including patented pheromone blends (Mosquito Aggregation Pheromone, Patent WO2019197681A1), phagostimulant compositions (HMBPP Phagostimulant, Patent WO2023057483A1), and attractants. These are delivered via NFC-tagged pheromone dispensers that provide 12 months of continuous, passive release. The products target Anopheles, Aedes, and Culex mosquito species through species-specific chemical blends that disrupt mating, swarming, and reproduction. The portfolio includes the Early Access Partnership Program for pre-market integration and the Refugee Response Program for humanitarian deployments with UNHCR. Applications span urban environments, leisure/hospitality settings (hotels, golf courses), and disaster relief operations.

Product and service6 records
1Ph Pheromones
CategoryPheromone-based mosquito control
Description

Patented mosquito-specific pheromone blends that disrupt mating, swarming, and reproduction by exploiting mosquitoes' own olfactory communication systems, targeting Anopheles, Aedes, and Culex species without affecting other insects. Used by public health authorities, humanitarian organizations, and hospitality customers for vector control.

2Phagostimulants
CategoryPheromone-based mosquito control
Description

Patented chemical blends based on HMBPP (E-4-hydroxy-3-methyl-but-2-enyl pyrophosphate) that stimulate mosquito feeding behavior and can be used in conjunction with pheromones to enhance mosquito control. Used in vector control programs targeting Anopheles, Aedes, and Culex mosquitoes.

3Attractants
CategoryPheromone-based mosquito control
Description

Species-specific volatile compound blends that lure mosquitoes by mimicking natural pheromones and feeding cues, used for population surveillance and control of Anopheles, Aedes, and Culex mosquitoes.

4Pheromone Dispensers
CategoryPheromone-based mosquito control
Description

NFC-tagged dispensers that provide continuous, passive release of the company's patented pheromone blends for 12 months at 1–2 grams per hectare per day, designed for installation by non-specialists on 50m x 50m grids without electricity or maintenance. Used by humanitarian organizations, government public health authorities, and hospitality customers for area-wide mosquito control.

5Early Access Partnership Program
CategoryPartnership / service program
Description

Pre-market access program providing targeted pheromone control technology to a strictly limited number of hospitality and enterprise properties for field trials, usability testing, and community engagement ahead of general availability. Customers include hotels, resorts, golf courses, and other leisure venues.

6Refugee Response Program
CategoryHumanitarian deployment program
Description

Pilot initiative with UNHCR deploying pheromone dispensers in refugee camps to protect populations from mosquito-borne diseases including dengue, malaria, and chikungunya without traditional insecticides, electricity, or maintenance. Initial deployment covers 10% of the Rohingya refugee camps before monsoon season, with full rollout planned for 2027.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Strategic partnership with UNHCR to deploy pheromone dispensers in Rohingya refugee camps in Cox's Bazar, Bangladesh. Pilot targets 10% of camps (143,000 people) at $0.96/person/year before monsoon season. Full rollout planned for 2027 to protect over 1 million people. Local staff recruited from among refugees. All permits secured from RRRC.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration with laboratories of founder Professor Noushin Emami. The partnership supports multidisciplinary research at the intersection of vector biology, olfactory signalling, and pathogen transmission. Central to developing next-generation, species-specific mosquito control solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration with laboratories of founder Professor Noushin Emami. Joint research efforts support multidisciplinary team working at intersection of vector biology, olfactory signalling, and pathogen transmission.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Oxitec
TypeDirect peer
Description

Oxitec develops and releases genetically modified mosquitoes (Friendly™ mosquitoes) for Aedes population suppression. It is the closest direct competitor to Molecular Attraction in species-specific, non-insecticidal vector control targeting the same Anopheles/Aedes/Culex disease vectors.

TypeDirect peer
Description

In2Care produces auto-dissemination trap stations that use pyriproxyfen and biological larvicides to control Aedes and other container-breeding mosquitoes. It is a direct competitor in targeted, trap-based mosquito control deployed by municipalities and public health authorities.

TypeDirect peer
Description

Biogents manufactures mosquito traps using patented lure blends (BG-Sweetscent, BG-Lure) that combine artificial host and sugar cues. It competes with Molecular Attraction in species-specific attractant-based surveillance and population reduction.

TypeDirect peer
Description

Suterra (a BASF subsidiary) is one of the world's leading pheromone-based pest control companies for agricultural pests such as codling moth and grapevine moth. It is the closest analog in pheromone-based pest control commercialization, even though it operates in agricultural rather than public-health mosquito control.

TypeEmerging player
Description

ISCA Technologies develops semiochemical and pheromone-based solutions for pest management across agriculture and vector control, including SPLAT and NOCTOS formulations. It overlaps with Molecular Attraction in species-specific pheromone R&D and formulation.

TypeEmerging player
Description

Vestaron develops peptide-based biopesticides targeting insect pests with novel modes of action to address resistance. It competes in the broader sustainable, non-chemical pest control category where Molecular Attraction also plays.

TypeBroad incumbent
Description

Anticimex is one of the largest global pest control service operators, offering mosquito, rodent, and general pest management to residential and commercial customers. It is both a financial investor in Molecular Attraction and a potential distribution partner for pheromone technology at scale.

TypeBroad incumbent
Description

Rentokil Initial is the world's largest commercial pest control services provider, operating across 80+ countries. It overlaps with Molecular Attraction in mosquito and vector control services, particularly for municipal and commercial accounts.

TypeBroad incumbent
Description

Sumitomo Chemical is a global manufacturer of vector control products including Olyset long-lasting insecticidal nets and SumiShield. It competes in mosquito-borne disease control across humanitarian and government channels where Molecular Attraction also sells.

TypeBroad incumbent
Description

SC Johnson markets OFF!, Raid, and Autan consumer mosquito repellent and insecticide brands globally. It represents the incumbent consumer/lifestyle segment that Molecular Attraction's hospitality/leisure GTM motion must compete against for mindshare and shelf space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Molecular Attraction

Pheromone-based mosquito control productsmolecular-attraction.com

Molecular Attraction is a Swedish bio-attractant company that develops patented, species-specific pheromone and phagostimulant dispensers for low-cost, maintenance-free mosquito control, serving humanitarian organizations, governments, and hospitality buyers.

What Molecular Attraction does

Molecular Attraction AB is a Swedish bio-attractant discovery company that develops species-specific pheromone-based products to control mosquitoes that transmit dengue, malaria, Zika, and chikungunya. Its platform isolates male aggregation pheromones directly from mosquito swarms and combines them with patented HMBPP phagostimulant compositions to disrupt mating, swarming, and feeding behavior in Anopheles, Aedes, and Culex species without affecting pollinators or other insects. Core products include pheromone blends, phagostimulants, and attractants delivered through NFC-tagged passive dispensers that release for 12 months at 1–2 grams per hectare per day, with no electricity or maintenance required. Field-validated performance includes an 80% mosquito population reduction reported in a 2024 whole-season trial in Dalarna, Sweden.

The company monetizes through hardware sales of pheromone dispensers priced at $0.26 per person protected at full deployment and $0.96 per person during pilots, with pilot deployments structured as multi-year contracts. Go-to-market is a hybrid model: an Early Access Partnership Program for commercial properties (hospitality, leisure, municipal buyers) and humanitarian deployments channeled through UNHCR, beginning with a 2025 pilot covering 143,000 Rohingya refugees in Cox's Bazar at a $137,000 contract value, with a 33-camp rollout to over 1 million people planned for 2027. Customers and trial sites span Sweden, the Seychelles, Spain, Argentina, and Bangladesh. The company is founder-led by Prof. Noushin Emami (Chief Scientific Officer) and chaired by Johan Paleovrachas, with Lech Ignatowicz as CEO, and is backed by Almi Invest, Farvatn Venture, the EIC Accelerator, EQT Foundation, Norrsken, Vinnova, and the European Union, alongside research collaborations with Karolinska Institute and the Liverpool School of Tropical Medicine.

Molecular Attraction firmographics

Firmographics
Name
Molecular Attraction
Legal name
Molecular Attraction AB
Website
https://molecular-attraction.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Molecular Attraction is a Swedish bio-attractant company that develops patented, species-specific pheromone and phagostimulant dispensers for low-cost, maintenance-free mosquito control, serving humanitarian organizations, governments, and hospitality buyers.
Ownership category
akta.pro rank

Molecular Attraction industry classification

Industry
Product category
Pheromone-based mosquito control products
NAICS
Pesticide and Other Agricultural Chemical Manufacturing (32532), Exterminating and Pest Control Services (56171), Surface Active Agent Manufacturing (325613), Pesticide and Other Agricultural Chemical Manufacturing (325320)
SIC
Agricultural Chemicals (2870), Industrial Organic Chemicals (2860), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYAFABAEAG
Semiochemicals & Pheromone-Based Control (Mating Disruption, Attract-and-Kill)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)

Keywords

  • Mosquito control solutions
  • Pheromone-based pest control
  • Vector control products
  • Bio-attractant discovery
  • Species-specific attractants

Where Molecular Attraction is headquartered

Location

Headquarters

HQ city
Nacka
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Molecular Attraction business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Pheromone Dispensers: Sale of patented pheromone dispensers for mosquito control. Products are designed for continuous passive release over 12 months, installed once and running maintenance-free. Pricing at $0.26 per person at full deployment and $0.96 per person during pilot phase.
  2. Pilot Program Revenue: Revenue from pilot deployments with organizations like UNHCR. The Rohingya refugee camp pilot costs $137,000 total, protecting 143,000 people at $0.96 per person. Full rollout projected at $290,000 for over 1 million people.
  3. Early Access Partnership Program: Exclusive pre-market access program for properties to receive targeted pheromone control technology before competitors. Limited onboarding for high-touch integration.

Pricing tiers

ModelBillingPrice
Unit PricingAnnualFull deployment pricing: $0.26 per person protected per year
Unit PricingMulti-year contractPilot deployment pricing: $0.96 per person protected per year

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Molecular Attraction product offering

Product offering

Core offering

Molecular Attraction develops and sells species-specific pheromone-based mosquito control products, including patented synthetic pheromone blends, HMBPP phagostimulant compositions, and species-specific attractants. The active ingredients are delivered via NFC-tagged pheromone dispensers that release continuously for 12 months at 1–2 grams per hectare per day, designed for installation by non-specialists without electricity or maintenance. The company's products are used by humanitarian organizations, government public health authorities, and leisure/hospitality properties to control Anopheles, Aedes, and Culex mosquitoes.

Product overview

Molecular Attraction develops a portfolio of pheromone-based mosquito control products including patented pheromone blends (Mosquito Aggregation Pheromone, Patent WO2019197681A1), phagostimulant compositions (HMBPP Phagostimulant, Patent WO2023057483A1), and attractants. These are delivered via NFC-tagged pheromone dispensers that provide 12 months of continuous, passive release. The products target Anopheles, Aedes, and Culex mosquito species through species-specific chemical blends that disrupt mating, swarming, and reproduction. The portfolio includes the Early Access Partnership Program for pre-market integration and the Refugee Response Program for humanitarian deployments with UNHCR. Applications span urban environments, leisure/hospitality settings (hotels, golf courses), and disaster relief operations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ph Pheromones Patented mosquito-specific pheromone blends that disrupt mating, swarming, and reproduction by exploiting mosquitoes' own olfactory communication systems, targeting Anopheles, Aedes, and Culex species without affecting other insects. Used by public health authorities, humanitarian organizations, and hospitality customers for vector control.
  • Phagostimulants Patented chemical blends based on HMBPP (E-4-hydroxy-3-methyl-but-2-enyl pyrophosphate) that stimulate mosquito feeding behavior and can be used in conjunction with pheromones to enhance mosquito control. Used in vector control programs targeting Anopheles, Aedes, and Culex mosquitoes.
  • Attractants Species-specific volatile compound blends that lure mosquitoes by mimicking natural pheromones and feeding cues, used for population surveillance and control of Anopheles, Aedes, and Culex mosquitoes.
  • Pheromone Dispensers NFC-tagged dispensers that provide continuous, passive release of the company's patented pheromone blends for 12 months at 1–2 grams per hectare per day, designed for installation by non-specialists on 50m x 50m grids without electricity or maintenance. Used by humanitarian organizations, government public health authorities, and hospitality customers for area-wide mosquito control.
  • Early Access Partnership Program Pre-market access program providing targeted pheromone control technology to a strictly limited number of hospitality and enterprise properties for field trials, usability testing, and community engagement ahead of general availability. Customers include hotels, resorts, golf courses, and other leisure venues.
  • Refugee Response Program Pilot initiative with UNHCR deploying pheromone dispensers in refugee camps to protect populations from mosquito-borne diseases including dengue, malaria, and chikungunya without traditional insecticides, electricity, or maintenance. Initial deployment covers 10% of the Rohingya refugee camps before monsoon season, with full rollout planned for 2027.

Quantifiable outcome

  • 80% mosquito population reduction in field trials (2024, Dalarna Region Sweden)
  • +5 more outcomes

Companies that use Molecular Attraction

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Molecular Attraction technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Molecular Attraction partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • UNHCRcoreStrategic or Co-development Partner · 1 January 2025Strategic partnership with UNHCR to deploy pheromone dispensers in Rohingya refugee camps in Cox's Bazar, Bangladesh. Pilot targets 10% of camps (143,000 people) at $0.96/person/year before monsoon season. Full rollout planned for 2027 to protect over 1 million people. Local staff recruited from among refugees. All permits secured from RRRC.
  • Karolinska InstitutecoreStrategic or Co-development PartnerResearch collaboration with laboratories of founder Professor Noushin Emami. The partnership supports multidisciplinary research at the intersection of vector biology, olfactory signalling, and pathogen transmission. Central to developing next-generation, species-specific mosquito control solutions.
  • Liverpool School of Tropical MedicinecoreStrategic or Co-development PartnerResearch collaboration with laboratories of founder Professor Noushin Emami. Joint research efforts support multidisciplinary team working at intersection of vector biology, olfactory signalling, and pathogen transmission.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Molecular Attraction competitors and assessment

Company assessment

Direct peers

  • Oxitec: Oxitec develops and releases genetically modified mosquitoes (Friendly™ mosquitoes) for Aedes population suppression. It is the closest direct competitor to Molecular Attraction in species-specific, non-insecticidal vector control targeting the same Anopheles/Aedes/Culex disease vectors.
  • In2Care: In2Care produces auto-dissemination trap stations that use pyriproxyfen and biological larvicides to control Aedes and other container-breeding mosquitoes. It is a direct competitor in targeted, trap-based mosquito control deployed by municipalities and public health authorities.
  • Biogents: Biogents manufactures mosquito traps using patented lure blends (BG-Sweetscent, BG-Lure) that combine artificial host and sugar cues. It competes with Molecular Attraction in species-specific attractant-based surveillance and population reduction.
  • Suterra: Suterra (a BASF subsidiary) is one of the world's leading pheromone-based pest control companies for agricultural pests such as codling moth and grapevine moth. It is the closest analog in pheromone-based pest control commercialization, even though it operates in agricultural rather than public-health mosquito control.

Emerging players

  • ISCA Technologies: ISCA Technologies develops semiochemical and pheromone-based solutions for pest management across agriculture and vector control, including SPLAT and NOCTOS formulations. It overlaps with Molecular Attraction in species-specific pheromone R&D and formulation.
  • Vestaron: Vestaron develops peptide-based biopesticides targeting insect pests with novel modes of action to address resistance. It competes in the broader sustainable, non-chemical pest control category where Molecular Attraction also plays.

Broad incumbents

  • Anticimex: Anticimex is one of the largest global pest control service operators, offering mosquito, rodent, and general pest management to residential and commercial customers. It is both a financial investor in Molecular Attraction and a potential distribution partner for pheromone technology at scale.
  • Rentokil Initial: Rentokil Initial is the world's largest commercial pest control services provider, operating across 80+ countries. It overlaps with Molecular Attraction in mosquito and vector control services, particularly for municipal and commercial accounts.
  • Sumitomo Chemical: Sumitomo Chemical is a global manufacturer of vector control products including Olyset long-lasting insecticidal nets and SumiShield. It competes in mosquito-borne disease control across humanitarian and government channels where Molecular Attraction also sells.
  • SC Johnson (OFF! and Raid): SC Johnson markets OFF!, Raid, and Autan consumer mosquito repellent and insecticide brands globally. It represents the incumbent consumer/lifestyle segment that Molecular Attraction's hospitality/leisure GTM motion must compete against for mindshare and shelf space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Molecular Attraction social profiles

Digital presence

Molecular Attraction financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Molecular Attraction leadership team

Management profile

Number of profiles

Profiles7 records

Molecular Attraction funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Molecular Attraction M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Molecular Attraction

What does Molecular Attraction do?

Molecular Attraction develops and sells species-specific pheromone-based mosquito control products, including patented synthetic pheromone blends, HMBPP phagostimulant compositions, and species-specific attractants. The active ingredients are delivered via NFC-tagged pheromone dispensers that release continuously for 12 months at 1–2 grams per hectare per day, designed for installation by non-specialists without electricity or maintenance. The company's products are used by humanitarian organizations, government public health authorities, and leisure/hospitality properties to control Anopheles, Aedes, and Culex mosquitoes.

Is Molecular Attraction a public or private company?

Molecular Attraction is a private company. It is classified as venture growth investor backed and is currently operating.

When was Molecular Attraction founded?

Molecular Attraction was founded in 2017. It employs 11 to 50 people.

Where is Molecular Attraction based?

Molecular Attraction is headquartered in Nacka, Sweden, in the Europe region.

How does Molecular Attraction make money?

Three revenue lines are on record. Pheromone Dispensers are the primary driver. The others are pilot Program Revenue and early Access Partnership Program.

Who are Molecular Attraction's main competitors?

Direct peers on record are Oxitec, In2Care, Biogents and Suterra. Emerging players are ISCA Technologies and Vestaron. Broad incumbents are Anticimex, Rentokil Initial, Sumitomo Chemical and SC Johnson (OFF! and Raid).

Does Molecular Attraction have an API?

No public API is recorded for Molecular Attraction.

What industry is Molecular Attraction in?

Molecular Attraction's product category is Pheromone-based mosquito control products. Its primary akta.pro industry code is AFABAEAG, Semiochemicals & Pheromone-Based Control (Mating Disruption, Attract-and-Kill). Its NAICS code is 32532 and its SIC code is 2870.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales